Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem. 1992;267:12424–7.

Article  CAS  Google Scholar 

Ma A, Malynn BA. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol. 2012;12:774–85. https://doi.org/10.1038/nri3313.

Article  CAS  Google Scholar 

Abbasi A, Forsberg K, Bischof F. The role of the ubiquitin-editing enzyme A20 in diseases of the central nervous system and other pathological processes. Front Mol Neurosci. 2015;8:21. https://doi.org/10.3389/fnmol.2015.00021.

Article  CAS  Google Scholar 

Musone SL, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008;40:1062–4. https://doi.org/10.1038/ng.202.

Article  CAS  Google Scholar 

Graham RR, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet. 2008;40:1059–61. https://doi.org/10.1038/ng.200.

Article  CAS  Google Scholar 

Dieguez-Gonzalez R, et al. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res Ther. 2009;11:R42. https://doi.org/10.1186/ar2650.

Article  CAS  Google Scholar 

Elsby LM, et al. Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis. Clin Exp Rheumatol. 2010;28:708–14.

CAS  Google Scholar 

Dieudé P, et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis. 2010;69:1958–64. https://doi.org/10.1136/ard.2009.127928.

Article  Google Scholar 

Zhou Q, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48:67–73. https://doi.org/10.1038/ng.3459.

Article  CAS  Google Scholar 

Bai W, Huo S, Li J, Shao J. Advances in the study of the ubiquitin-editing enzyme A20. Front Pharmacol. 2022;13:845262. https://doi.org/10.3389/fphar.2022.845262.

Article  CAS  Google Scholar 

Wertz IE, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430:694–9. https://doi.org/10.1038/nature02794.

Article  CAS  Google Scholar 

Lu TT, et al. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity. 2013;38:896–905. https://doi.org/10.1016/j.immuni.2013.03.008.

Article  CAS  Google Scholar 

Zammit NW, et al. Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity. Nat Immunol. 2019;20:1299–310. https://doi.org/10.1038/s41590-019-0492-0.

Article  CAS  Google Scholar 

El Khouri E. et al. A critical region of A20 unveiled by missense TNFAIP3 variations that lead to autoinflammation. Elife. 2023;12. https://doi.org/10.7554/eLife.81280.

Shembade N, Harhaj EW. Regulation of NF-kappaB signaling by the A20 deubiquitinase. Cell Mol Immunol. 2012;9:123–30. https://doi.org/10.1038/cmi.2011.59.

Article  CAS  Google Scholar 

Kulathu Y, et al. Regulation of A20 and other OTU deubiquitinases by reversible oxidation. Nat Commun. 2013;4:1569. https://doi.org/10.1038/ncomms2567.

Article  CAS  Google Scholar 

Martens A, et al. Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities. Nat Immunol. 2020;21:381–7. https://doi.org/10.1038/s41590-020-0621-9.

Article  CAS  Google Scholar 

Bosanac I, et al. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling. Mol Cell. 2010;40:548–57. https://doi.org/10.1016/j.molcel.2010.10.009.

Article  CAS  Google Scholar 

Wertz IE, et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature. 2015;528:370–5. https://doi.org/10.1038/nature16165.

Article  CAS  Google Scholar 

Shembade N, et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat Immunol. 2008;9:254–62. https://doi.org/10.1038/ni1563.

Article  CAS  Google Scholar 

Shembade N, Parvatiyar K, Harhaj NS, Harhaj EW. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling. EMBO J. 2009;28:513–22. https://doi.org/10.1038/emboj.2008.285.

Article  CAS  Google Scholar 

Razani B, et al. Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation. Nat Immunol. 2020;21:422–33. https://doi.org/10.1038/s41590-020-0634-4.

Article  CAS  Google Scholar 

Li L, Soetandyo N, Wang Q, Ye Y. The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation. Biochim Biophys Acta. 2009;1793:346–53. https://doi.org/10.1016/j.bbamcr.2008.09.013.

Article  CAS  Google Scholar 

Düwel M, et al. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J Immunol. 2009;182:7718–28. https://doi.org/10.4049/jimmunol.0803313.

Article  CAS  Google Scholar 

Gough P, Myles IA. Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects. Front Immunol. 2020;11:585880. https://doi.org/10.3389/fimmu.2020.585880.

Article  CAS  Google Scholar 

Priem D, et al. A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms. Cell Death Dis. 2019;10:692. https://doi.org/10.1038/s41419-019-1937-y.

Article  CAS  Google Scholar 

Song HY, Rothe M, Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci U S A. 1996;93:6721-6725.https://doi.org/10.1073/pnas.93.13.6721.

Meng Z, et al. A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48- and K63-linked polyubiquitination of effectors MyD88 and TBK1. J Biol Chem. 2021;297:100811. https://doi.org/10.1016/j.jbc.2021.100811.

Article  CAS  Google Scholar 

De Wilde K, et al. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis. Ann Rheum Dis. 2017;76:585–92. https://doi.org/10.1136/annrheumdis-2016-209454.

Article  CAS  Google Scholar 

Moll HP, et al. A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels. J Biol Chem. 2014;289:30912–24. https://doi.org/10.1074/jbc.M114.591966.

Article  CAS  Google Scholar 

Almeida-da-Silva CLC, Savio LEB, Coutinho-Silva R, Ojcius DM. The role of NOD-like receptors in innate immunity. Front Immunol. 2023;14:1122586. https://doi.org/10.3389/fimmu.2023.1122586.

Article  CAS  Google Scholar 

Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10:128. https://doi.org/10.1038/s41419-019-1413-8.

Article  Google Scholar 

Das T, Chen Z, Hendriks RW, Kool M. A20/tumor necrosis factor α-induced protein 3 in immune cells controls development of autoinflammation and autoimmunity: lessons from mouse models. Front Immunol. 2018;9:104. https://doi.org/10.3389/fimmu.2018.00104.

Article  CAS  Google Scholar 

Duong BH, et al. A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity. Immunity. 2015;42:55–67. https://doi.org/10.1016/j.immuni.2014.12.031.

Article  CAS  Google Scholar 

VandeWalle L, et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature. 2014;512:69–73.

Article  Google Scholar 

Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16:689–97. https://doi.org/10.1038/ni.3206.

Article  CAS  Google Scholar 

Onizawa M, et al. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat Immunol. 2015;16:618–27. https://doi.org/10.1038/ni.3172.

Article  CAS  Google Scholar 

Lee EG, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289:2350–4. https://doi.org/10.1126/science.289.5488.2350.

Article  CAS  Google Scholar 

Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181–90. https://doi.org/10.1016/s0092-8674(03)00521-x.

Article  CAS  Google Scholar 

Lim MCC, et al. Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death. Cell Death Differ. 2017;24:1621–31. https://doi.org/10.1038/cdd.2017.89.

Article  CAS  Google Scholar 

Kattah MG, et al. A20 and ABIN-1 synergistically preserve intestinal epithelial cell survival. J Exp Med. 2018;215:1839–52. https://doi.org/10.1084/jem.20180198.

Article  CAS  Google Scholar 

Won M, et al. Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. Cell Death Differ. 2010;17:1830–41. https://doi.org/10.1038/cdd.2010.47.

Article  CAS  Google Scholar 

Adrianto I, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet. 2011;43:253–8. https://doi.org/10.1038/ng.766.

Article  CAS